A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly injection has been shown to be as effective as Mounjaro – but patients don’t experience one of the least-favourable side effects of weight loss jabs. Eloralintide, an amylin analog injection that’s been produced by Eli…
